Research programme: antidepressants - UCB
Alternative Names: UCB-46331Latest Information Update: 04 Nov 2017
At a glance
- Originator UCB
- Class
- Mechanism of Action Histamine H1 receptor antagonists; Serotonin 5-HT2 receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Major depressive disorder in Belgium (PO)
- 11 Oct 2006 A lead compound from this programme has entered phase I development
- 30 Mar 2006 Preclinical trials in Depression in Belgium (PO)